top of page

ΙNFRAFRONTIER / IMPC Stakeholder Meeting 2018

Advancing Rare Disease Research and Gene Therapy Applications with Animal Models, 3-4 Dec 2018, Munich

IF-IMPC Optical_square.png


















The second Stakeholder Meeting of INFRAFRONTIER, the European Research Infrastructure for phenotyping and archiving of model mammalian genomes, will be jointly organized with the International Mouse Phenotyping Consortium (IMPC). The thematic focus of the meeting is on advancing Rare Disease research and gene therapy applications with animal models.


The Stakeholder Meeting provides an excellent opportunity to support a better alignment of INFRAFRONTIER / IMPC platforms with current Rare Disease research and personalised medicine initiatives and supports interactions with human genetics centers and clinical consortia. New partnerships can support the rapid impact of mouse functional genomics analyses on the understanding of human genetic variation and disease, and the translation into diagnostic and therapeutic approaches.


The Stakeholder Meeting will be structured into three main parts:

  • Advancing Rare Disease research with animal models

  • Gene therapy applications using animal models

  • Young Investigator / Stakeholder presentations


Meeting aims are to:

  • Raise awareness of INFRAFRONTIER / IMPC platforms among the Rare Disease community

  • Present use cases for the utility of animal models to advance Rare Disease research 

  • Share advances in gene therapy applications, including gene-editing approaches to cure human diseases

  • Strengthen interactions with Rare Disease and clinical research consortia

  • Support presentation of use cases by Young Investigators


Programme outline

Session topics


Monday, December 3

  • Model organisms facilitate Rare Disease diagnosis and therapeutic research

  • Genomic Medicine and EU collaborative initiatives targeting Rare Diseases

  • Funder and regulator perspectives on Rare Disease modeling and gene therapy applications  

  • Poster session

  • Young investigator presentations

  • Panel discussion: Advancing Rare Disease diagnosis and therapeutic research with model organisms - building bridges between basic and clinical research


Tuesday, December 4

  • Animal models for human gene therapy applications

  • Gene editing in gene therapy of human (rare) diseases

  • Optimising gene editing for therapeutics

  • Gene editing for advanced therapies – Ethics, governance, policy, and society

  • Young investigator presentations


Meeting venue

Hilton Munich Park Hotel

Situated on the edge of Munich's famous public park `Englischer Garten´, Hilton Munich Park Hotel is a modern, elegant International Business Hotel with all the amenities you may expect. The hotel is only a 30 minutes drive away from Munich airport and within easy reach of all of the city's major businesses and attractions.


Hilton Munich Park Hotel

Am Tucherpark 7

D - 80538 Munich, Germany


bottom of page